Search research articles
Contact Us
Filters
Showing results (1-10 of 169) with videos related to
Page
of 17
Sort By:
British Journal of Clinical Pharmacology
|
September 1, 1982
Statistical significance tests
D R Cox
Experimental Cell Research
|
March 15, 1976
Evidence for enzyme subunit complementation in somatic cell heterokaryons
D R Cox
JAMA
|
July 15, 1992
Medical genetics
D R Cox
Mead Johnson Symposium on Perinatal and Developmental Medicine
|
January 1, 1983
Mouse trisomy 16 as an animal model of human trisomy 21: a new approach for studying the pathogenesis of Down syndrome
D R Cox
Statistics in Medicine
|
December 20, 2014
Multivariate meta-analysis: a comment
D R Cox
Cancer Treatment Reports
|
February 1, 1980
Proceedings of the Symposium on Designs for Clinical Cancer Research. Summary views: A statistician's perspective
D R Cox
Lifetime Data Analysis
|
January 29, 2000
Some remarks on failure-times, surrogate markers, degradation, wear, and the quality of life
D R Cox
Physical Therapy
|
August 22, 2001
Another comment on the role of statistical methods
D R Cox
Cytogenetics and Cell Genetics
|
January 1, 1992
Radiation hybrid mapping
D R Cox
Biostatistics (Oxford, England)
|
September 27, 2013
Discussion: Comment on a paper by Jager and Leek
D R Cox
Page
of 17
Search research articles
Search
Showing results (1-10 of 169) with videos related to
Sort By:
Page
of 17
British Journal of Clinical Pharmacology
|
September 1, 1982
Statistical significance tests
D R Cox
Experimental Cell Research
|
March 15, 1976
Evidence for enzyme subunit complementation in somatic cell heterokaryons
D R Cox
JAMA
|
July 15, 1992
Medical genetics
D R Cox
Mead Johnson Symposium on Perinatal and Developmental Medicine
|
January 1, 1983
Mouse trisomy 16 as an animal model of human trisomy 21: a new approach for studying the pathogenesis of Down syndrome
D R Cox
Statistics in Medicine
|
December 20, 2014
Multivariate meta-analysis: a comment
D R Cox
Cancer Treatment Reports
|
February 1, 1980
Proceedings of the Symposium on Designs for Clinical Cancer Research. Summary views: A statistician's perspective
D R Cox
Lifetime Data Analysis
|
January 29, 2000
Some remarks on failure-times, surrogate markers, degradation, wear, and the quality of life
D R Cox
Physical Therapy
|
August 22, 2001
Another comment on the role of statistical methods
D R Cox
Cytogenetics and Cell Genetics
|
January 1, 1992
Radiation hybrid mapping
D R Cox
Biostatistics (Oxford, England)
|
September 27, 2013
Discussion: Comment on a paper by Jager and Leek
D R Cox
Page
of 17